nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—asthma—chronic obstructive pulmonary disease	0.25	1	CtDrD
Indacaterol—Adrenergic beta2-Agonists—Salbutamol—chronic obstructive pulmonary disease	0.148	0.333	CiPCiCtD
Indacaterol—Adrenergic beta2-Agonists—Formoterol—chronic obstructive pulmonary disease	0.148	0.333	CiPCiCtD
Indacaterol—Adrenergic beta2-Agonists—Arformoterol—chronic obstructive pulmonary disease	0.148	0.333	CiPCiCtD
Indacaterol—ADRB2—chronic obstructive pulmonary disease	0.105	1	CbGaD
Indacaterol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.027	0.174	CbGbCtD
Indacaterol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0266	0.172	CbGbCtD
Indacaterol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0205	0.132	CbGbCtD
Indacaterol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0205	0.132	CbGbCtD
Indacaterol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0202	0.13	CbGbCtD
Indacaterol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0202	0.13	CbGbCtD
Indacaterol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00431	0.0278	CbGbCtD
Indacaterol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.0188	CbGbCtD
Indacaterol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00278	0.0179	CbGbCtD
Indacaterol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00247	0.016	CbGbCtD
Indacaterol—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00242	0.0156	CbGbCtD
Indacaterol—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00229	0.0148	CbGbCtD
Indacaterol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.00937	CbGbCtD
Indacaterol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00885	CbGbCtD
Indacaterol—Procaterol—ADRB2—chronic obstructive pulmonary disease	0.00112	1	CrCbGaD
Indacaterol—UGT1A1—Heme degradation—HMOX1—chronic obstructive pulmonary disease	0.000362	0.0569	CbGpPWpGaD
Indacaterol—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.000307	0.00802	CcSEcCtD
Indacaterol—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0003	0.0471	CbGpPWpGaD
Indacaterol—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000265	0.0416	CbGpPWpGaD
Indacaterol—Rhinorrhoea—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00642	CcSEcCtD
Indacaterol—ADRB1—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.000244	0.0383	CbGpPWpGaD
Indacaterol—Myocardial ischaemia—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00624	CcSEcCtD
Indacaterol—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.000225	0.00589	CcSEcCtD
Indacaterol—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.000224	0.00586	CcSEcCtD
Indacaterol—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.000224	0.00586	CcSEcCtD
Indacaterol—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00567	CcSEcCtD
Indacaterol—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000217	0.034	CbGpPWpGaD
Indacaterol—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.00021	0.00549	CcSEcCtD
Indacaterol—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.00535	CcSEcCtD
Indacaterol—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.000198	0.00517	CcSEcCtD
Indacaterol—Musculoskeletal pain—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00508	CcSEcCtD
Indacaterol—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.000187	0.00488	CcSEcCtD
Indacaterol—UGT1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.0287	CbGpPWpGaD
Indacaterol—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000182	0.00475	CcSEcCtD
Indacaterol—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000181	0.00474	CcSEcCtD
Indacaterol—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.00461	CcSEcCtD
Indacaterol—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.000175	0.00458	CcSEcCtD
Indacaterol—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000168	0.0044	CcSEcCtD
Indacaterol—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000164	0.00429	CcSEcCtD
Indacaterol—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00419	CcSEcCtD
Indacaterol—UGT1A1—Porphyrin metabolism—HMOX1—chronic obstructive pulmonary disease	0.000158	0.0247	CbGpPWpGaD
Indacaterol—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000157	0.00411	CcSEcCtD
Indacaterol—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00407	CcSEcCtD
Indacaterol—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00407	CcSEcCtD
Indacaterol—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000155	0.00404	CcSEcCtD
Indacaterol—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00402	CcSEcCtD
Indacaterol—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00395	CcSEcCtD
Indacaterol—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000149	0.0039	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000148	0.00387	CcSEcCtD
Indacaterol—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00384	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00384	CcSEcCtD
Indacaterol—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.000143	0.00373	CcSEcCtD
Indacaterol—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000142	0.00371	CcSEcCtD
Indacaterol—UGT1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00014	0.022	CbGpPWpGaD
Indacaterol—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00014	0.00366	CcSEcCtD
Indacaterol—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000139	0.00363	CcSEcCtD
Indacaterol—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00351	CcSEcCtD
Indacaterol—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00351	CcSEcCtD
Indacaterol—UGT1A1—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.0209	CbGpPWpGaD
Indacaterol—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.00346	CcSEcCtD
Indacaterol—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00345	CcSEcCtD
Indacaterol—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00345	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00013	0.0034	CcSEcCtD
Indacaterol—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00338	CcSEcCtD
Indacaterol—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00333	CcSEcCtD
Indacaterol—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00333	CcSEcCtD
Indacaterol—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00331	CcSEcCtD
Indacaterol—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00328	CcSEcCtD
Indacaterol—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00328	CcSEcCtD
Indacaterol—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00327	CcSEcCtD
Indacaterol—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.00326	CcSEcCtD
Indacaterol—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00326	CcSEcCtD
Indacaterol—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.00325	CcSEcCtD
Indacaterol—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00325	CcSEcCtD
Indacaterol—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00325	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000123	0.00322	CcSEcCtD
Indacaterol—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00315	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000119	0.0031	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.0031	CcSEcCtD
Indacaterol—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.0031	CcSEcCtD
Indacaterol—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00307	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00303	CcSEcCtD
Indacaterol—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00301	CcSEcCtD
Indacaterol—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00301	CcSEcCtD
Indacaterol—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000114	0.00299	CcSEcCtD
Indacaterol—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000114	0.00298	CcSEcCtD
Indacaterol—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00293	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00293	CcSEcCtD
Indacaterol—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00291	CcSEcCtD
Indacaterol—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00291	CcSEcCtD
Indacaterol—ADRB1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.0173	CbGpPWpGaD
Indacaterol—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.00288	CcSEcCtD
Indacaterol—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.0173	CbGpPWpGaD
Indacaterol—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.00286	CcSEcCtD
Indacaterol—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00284	CcSEcCtD
Indacaterol—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00279	CcSEcCtD
Indacaterol—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00279	CcSEcCtD
Indacaterol—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000105	0.00275	CcSEcCtD
Indacaterol—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00273	CcSEcCtD
Indacaterol—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.0027	CcSEcCtD
Indacaterol—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00263	CcSEcCtD
Indacaterol—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00263	CcSEcCtD
Indacaterol—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00263	CcSEcCtD
Indacaterol—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.0001	0.00262	CcSEcCtD
Indacaterol—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.00262	CcSEcCtD
Indacaterol—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	9.83e-05	0.00257	CcSEcCtD
Indacaterol—Palpitations—Tiotropium—chronic obstructive pulmonary disease	9.73e-05	0.00254	CcSEcCtD
Indacaterol—Cough—Tiotropium—chronic obstructive pulmonary disease	9.61e-05	0.00251	CcSEcCtD
Indacaterol—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	9.48e-05	0.00248	CcSEcCtD
Indacaterol—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	9.48e-05	0.00248	CcSEcCtD
Indacaterol—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	9.47e-05	0.00248	CcSEcCtD
Indacaterol—Infection—Aminophylline—chronic obstructive pulmonary disease	9.47e-05	0.00247	CcSEcCtD
Indacaterol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	9.45e-05	0.00247	CcSEcCtD
Indacaterol—Chest pain—Tiotropium—chronic obstructive pulmonary disease	9.38e-05	0.00245	CcSEcCtD
Indacaterol—Myalgia—Tiotropium—chronic obstructive pulmonary disease	9.38e-05	0.00245	CcSEcCtD
Indacaterol—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	9.35e-05	0.00244	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	9.31e-05	0.00243	CcSEcCtD
Indacaterol—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	9.3e-05	0.00243	CcSEcCtD
Indacaterol—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	9.28e-05	0.00243	CcSEcCtD
Indacaterol—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	9.22e-05	0.00241	CcSEcCtD
Indacaterol—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	9.22e-05	0.00241	CcSEcCtD
Indacaterol—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	9.2e-05	0.0024	CcSEcCtD
Indacaterol—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	9.2e-05	0.0024	CcSEcCtD
Indacaterol—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	9.19e-05	0.0024	CcSEcCtD
Indacaterol—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	9.17e-05	0.0024	CcSEcCtD
Indacaterol—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	9.03e-05	0.00236	CcSEcCtD
Indacaterol—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	9.01e-05	0.00236	CcSEcCtD
Indacaterol—Rash—Roflumilast—chronic obstructive pulmonary disease	9.01e-05	0.00236	CcSEcCtD
Indacaterol—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	9e-05	0.00235	CcSEcCtD
Indacaterol—Headache—Roflumilast—chronic obstructive pulmonary disease	8.95e-05	0.00234	CcSEcCtD
Indacaterol—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	8.95e-05	0.00234	CcSEcCtD
Indacaterol—Infection—Tiotropium—chronic obstructive pulmonary disease	8.93e-05	0.00233	CcSEcCtD
Indacaterol—Malnutrition—Formoterol—chronic obstructive pulmonary disease	8.89e-05	0.00232	CcSEcCtD
Indacaterol—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	8.89e-05	0.00232	CcSEcCtD
Indacaterol—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	8.81e-05	0.0023	CcSEcCtD
Indacaterol—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	8.77e-05	0.00229	CcSEcCtD
Indacaterol—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	8.73e-05	0.00228	CcSEcCtD
Indacaterol—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	8.71e-05	0.00228	CcSEcCtD
Indacaterol—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.69e-05	0.00227	CcSEcCtD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	8.64e-05	0.0136	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	8.63e-05	0.0135	CbGpPWpGaD
Indacaterol—ADRB1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	8.55e-05	0.0134	CbGpPWpGaD
Indacaterol—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	8.54e-05	0.00223	CcSEcCtD
Indacaterol—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	8.54e-05	0.00223	CcSEcCtD
Indacaterol—Nausea—Roflumilast—chronic obstructive pulmonary disease	8.49e-05	0.00222	CcSEcCtD
Indacaterol—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	8.44e-05	0.0132	CbGpPWpGaD
Indacaterol—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	8.39e-05	0.00219	CcSEcCtD
Indacaterol—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	8.37e-05	0.00219	CcSEcCtD
Indacaterol—Tremor—Arformoterol—chronic obstructive pulmonary disease	8.33e-05	0.00218	CcSEcCtD
Indacaterol—Tremor—Formoterol—chronic obstructive pulmonary disease	8.33e-05	0.00218	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	8.19e-05	0.00214	CcSEcCtD
Indacaterol—Tremor—Montelukast—chronic obstructive pulmonary disease	8.16e-05	0.00213	CcSEcCtD
Indacaterol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	8.07e-05	0.00211	CcSEcCtD
Indacaterol—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	8.07e-05	0.00211	CcSEcCtD
Indacaterol—ADRB1—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	8.01e-05	0.0126	CbGpPWpGaD
Indacaterol—Tremor—Salbutamol—chronic obstructive pulmonary disease	7.86e-05	0.00205	CcSEcCtD
Indacaterol—Palpitations—Formoterol—chronic obstructive pulmonary disease	7.85e-05	0.00205	CcSEcCtD
Indacaterol—Palpitations—Arformoterol—chronic obstructive pulmonary disease	7.85e-05	0.00205	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	7.76e-05	0.00203	CcSEcCtD
Indacaterol—Cough—Arformoterol—chronic obstructive pulmonary disease	7.76e-05	0.00203	CcSEcCtD
Indacaterol—Cough—Formoterol—chronic obstructive pulmonary disease	7.76e-05	0.00203	CcSEcCtD
Indacaterol—ADRB1—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	7.71e-05	0.0121	CbGpPWpGaD
Indacaterol—Palpitations—Montelukast—chronic obstructive pulmonary disease	7.69e-05	0.00201	CcSEcCtD
Indacaterol—Cough—Montelukast—chronic obstructive pulmonary disease	7.6e-05	0.00199	CcSEcCtD
Indacaterol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	7.57e-05	0.00198	CcSEcCtD
Indacaterol—Myalgia—Arformoterol—chronic obstructive pulmonary disease	7.57e-05	0.00198	CcSEcCtD
Indacaterol—Chest pain—Formoterol—chronic obstructive pulmonary disease	7.57e-05	0.00198	CcSEcCtD
Indacaterol—Myalgia—Formoterol—chronic obstructive pulmonary disease	7.57e-05	0.00198	CcSEcCtD
Indacaterol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	7.54e-05	0.00197	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	7.51e-05	0.00196	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	7.51e-05	0.00196	CcSEcCtD
Indacaterol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	7.42e-05	0.00194	CcSEcCtD
Indacaterol—Myalgia—Montelukast—chronic obstructive pulmonary disease	7.41e-05	0.00194	CcSEcCtD
Indacaterol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	7.4e-05	0.00193	CcSEcCtD
Indacaterol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	7.4e-05	0.00193	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	7.36e-05	0.00192	CcSEcCtD
Indacaterol—Cough—Salbutamol—chronic obstructive pulmonary disease	7.32e-05	0.00191	CcSEcCtD
Indacaterol—ADRB1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	7.25e-05	0.0114	CbGpPWpGaD
Indacaterol—Infection—Arformoterol—chronic obstructive pulmonary disease	7.21e-05	0.00188	CcSEcCtD
Indacaterol—Infection—Formoterol—chronic obstructive pulmonary disease	7.21e-05	0.00188	CcSEcCtD
Indacaterol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	7.14e-05	0.00187	CcSEcCtD
Indacaterol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	7.14e-05	0.00187	CcSEcCtD
Indacaterol—UGT1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.14e-05	0.0112	CbGpPWpGaD
Indacaterol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	7.11e-05	0.00186	CcSEcCtD
Indacaterol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	7.11e-05	0.00186	CcSEcCtD
Indacaterol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	7.08e-05	0.00185	CcSEcCtD
Indacaterol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	7.08e-05	0.00185	CcSEcCtD
Indacaterol—Infection—Montelukast—chronic obstructive pulmonary disease	7.06e-05	0.00184	CcSEcCtD
Indacaterol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	7.05e-05	0.00184	CcSEcCtD
Indacaterol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	7.05e-05	0.00184	CcSEcCtD
Indacaterol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	7.02e-05	0.00184	CcSEcCtD
Indacaterol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	6.99e-05	0.00183	CcSEcCtD
Indacaterol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	6.97e-05	0.00182	CcSEcCtD
Indacaterol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	6.9e-05	0.0018	CcSEcCtD
Indacaterol—Infection—Salbutamol—chronic obstructive pulmonary disease	6.8e-05	0.00178	CcSEcCtD
Indacaterol—ADRB1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	6.74e-05	0.0106	CbGpPWpGaD
Indacaterol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	6.74e-05	0.00176	CcSEcCtD
Indacaterol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	6.72e-05	0.00176	CcSEcCtD
Indacaterol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	6.68e-05	0.00175	CcSEcCtD
Indacaterol—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.00175	CcSEcCtD
Indacaterol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	6.65e-05	0.00174	CcSEcCtD
Indacaterol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	6.62e-05	0.00173	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	6.61e-05	0.00173	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	6.61e-05	0.00173	CcSEcCtD
Indacaterol—ADRB2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	6.6e-05	0.0104	CbGpPWpGaD
Indacaterol—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	6.54e-05	0.0103	CbGpPWpGaD
Indacaterol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	6.47e-05	0.00169	CcSEcCtD
Indacaterol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	6.47e-05	0.00169	CcSEcCtD
Indacaterol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	6.47e-05	0.00169	CcSEcCtD
Indacaterol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	6.38e-05	0.00167	CcSEcCtD
Indacaterol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	6.36e-05	0.00166	CcSEcCtD
Indacaterol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.3e-05	0.00165	CcSEcCtD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	6.28e-05	0.00985	CbGpPWpGaD
Indacaterol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	6.26e-05	0.00164	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	6.26e-05	0.00164	CcSEcCtD
Indacaterol—UGT1A1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	6.26e-05	0.00982	CbGpPWpGaD
Indacaterol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.24e-05	0.00163	CcSEcCtD
Indacaterol—UGT1A1—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	6.19e-05	0.00971	CbGpPWpGaD
Indacaterol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	6.15e-05	0.00161	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.13e-05	0.0016	CcSEcCtD
Indacaterol—UGT1A1—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	6.11e-05	0.0096	CbGpPWpGaD
Indacaterol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	6.11e-05	0.0016	CcSEcCtD
Indacaterol—Rash—Aminophylline—chronic obstructive pulmonary disease	6.01e-05	0.00157	CcSEcCtD
Indacaterol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	6e-05	0.00157	CcSEcCtD
Indacaterol—ADRB2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	5.97e-05	0.00938	CbGpPWpGaD
Indacaterol—Headache—Aminophylline—chronic obstructive pulmonary disease	5.97e-05	0.00156	CcSEcCtD
Indacaterol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	5.94e-05	0.00155	CcSEcCtD
Indacaterol—ADRB1—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	5.92e-05	0.00928	CbGpPWpGaD
Indacaterol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	5.91e-05	0.00155	CcSEcCtD
Indacaterol—ADRB2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	5.79e-05	0.00908	CbGpPWpGaD
Indacaterol—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	5.68e-05	0.00892	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	5.67e-05	0.0089	CbGpPWpGaD
Indacaterol—Rash—Tiotropium—chronic obstructive pulmonary disease	5.67e-05	0.00148	CcSEcCtD
Indacaterol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	5.66e-05	0.00148	CcSEcCtD
Indacaterol—Nausea—Aminophylline—chronic obstructive pulmonary disease	5.66e-05	0.00148	CcSEcCtD
Indacaterol—Headache—Tiotropium—chronic obstructive pulmonary disease	5.63e-05	0.00147	CcSEcCtD
Indacaterol—ADRB2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	5.54e-05	0.0087	CbGpPWpGaD
Indacaterol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.34e-05	0.0014	CcSEcCtD
Indacaterol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.34e-05	0.0014	CcSEcCtD
Indacaterol—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.34e-05	0.0014	CcSEcCtD
Indacaterol—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.00138	CcSEcCtD
Indacaterol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.23e-05	0.00137	CcSEcCtD
Indacaterol—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	5.17e-05	0.00812	CbGpPWpGaD
Indacaterol—UGT1A1—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	5.14e-05	0.00807	CbGpPWpGaD
Indacaterol—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.13e-05	0.00134	CcSEcCtD
Indacaterol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.13e-05	0.00134	CcSEcCtD
Indacaterol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	5.05e-05	0.00132	CcSEcCtD
Indacaterol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	5.05e-05	0.00792	CbGpPWpGaD
Indacaterol—Pruritus—Montelukast—chronic obstructive pulmonary disease	5.03e-05	0.00131	CcSEcCtD
Indacaterol—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	4.95e-05	0.00777	CbGpPWpGaD
Indacaterol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	4.85e-05	0.00127	CcSEcCtD
Indacaterol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	4.8e-05	0.00125	CcSEcCtD
Indacaterol—Dizziness—Formoterol—chronic obstructive pulmonary disease	4.8e-05	0.00125	CcSEcCtD
Indacaterol—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	4.75e-05	0.00746	CbGpPWpGaD
Indacaterol—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.7e-05	0.00123	CcSEcCtD
Indacaterol—ADRB1—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	4.7e-05	0.00737	CbGpPWpGaD
Indacaterol—Rash—Formoterol—chronic obstructive pulmonary disease	4.57e-05	0.0012	CcSEcCtD
Indacaterol—Rash—Arformoterol—chronic obstructive pulmonary disease	4.57e-05	0.0012	CcSEcCtD
Indacaterol—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	4.57e-05	0.00717	CbGpPWpGaD
Indacaterol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.57e-05	0.00119	CcSEcCtD
Indacaterol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.57e-05	0.00119	CcSEcCtD
Indacaterol—Headache—Formoterol—chronic obstructive pulmonary disease	4.54e-05	0.00119	CcSEcCtD
Indacaterol—Headache—Arformoterol—chronic obstructive pulmonary disease	4.54e-05	0.00119	CcSEcCtD
Indacaterol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.53e-05	0.00118	CcSEcCtD
Indacaterol—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.00118	CcSEcCtD
Indacaterol—Rash—Montelukast—chronic obstructive pulmonary disease	4.48e-05	0.00117	CcSEcCtD
Indacaterol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.48e-05	0.00117	CcSEcCtD
Indacaterol—UGT1A1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	4.46e-05	0.007	CbGpPWpGaD
Indacaterol—Headache—Montelukast—chronic obstructive pulmonary disease	4.45e-05	0.00116	CcSEcCtD
Indacaterol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	4.32e-05	0.00113	CcSEcCtD
Indacaterol—Rash—Salbutamol—chronic obstructive pulmonary disease	4.32e-05	0.00113	CcSEcCtD
Indacaterol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.31e-05	0.00113	CcSEcCtD
Indacaterol—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.31e-05	0.00113	CcSEcCtD
Indacaterol—Nausea—Formoterol—chronic obstructive pulmonary disease	4.31e-05	0.00113	CcSEcCtD
Indacaterol—Headache—Salbutamol—chronic obstructive pulmonary disease	4.29e-05	0.00112	CcSEcCtD
Indacaterol—UGT1A1—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	4.29e-05	0.00673	CbGpPWpGaD
Indacaterol—Nausea—Montelukast—chronic obstructive pulmonary disease	4.22e-05	0.0011	CcSEcCtD
Indacaterol—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	4.13e-05	0.00648	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	4.08e-05	0.0064	CbGpPWpGaD
Indacaterol—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.07e-05	0.00106	CcSEcCtD
Indacaterol—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	3.96e-05	0.00622	CbGpPWpGaD
Indacaterol—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.00103	CcSEcCtD
Indacaterol—UGT1A1—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.94e-05	0.00618	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	3.87e-05	0.00607	CbGpPWpGaD
Indacaterol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	3.83e-05	0.001	CcSEcCtD
Indacaterol—UGT1A1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	3.79e-05	0.00595	CbGpPWpGaD
Indacaterol—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.76e-05	0.0059	CbGpPWpGaD
Indacaterol—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	3.63e-05	0.000948	CcSEcCtD
Indacaterol—UGT1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.62e-05	0.00568	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.58e-05	0.00561	CbGpPWpGaD
Indacaterol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	3.53e-05	0.000922	CcSEcCtD
Indacaterol—Malnutrition—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.000914	CcSEcCtD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	3.47e-05	0.00545	CbGpPWpGaD
Indacaterol—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	3.45e-05	0.00542	CbGpPWpGaD
Indacaterol—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.32e-05	0.00521	CbGpPWpGaD
Indacaterol—Anaemia—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.000845	CcSEcCtD
Indacaterol—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	3.15e-05	0.00494	CbGpPWpGaD
Indacaterol—Vertigo—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000821	CcSEcCtD
Indacaterol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	3.11e-05	0.00488	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.01e-05	0.00472	CbGpPWpGaD
Indacaterol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	2.99e-05	0.00469	CbGpPWpGaD
Indacaterol—Myalgia—Prednisone—chronic obstructive pulmonary disease	2.98e-05	0.000778	CcSEcCtD
Indacaterol—UGT1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.97e-05	0.00465	CbGpPWpGaD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	2.96e-05	0.000773	CcSEcCtD
Indacaterol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	2.93e-05	0.0046	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	2.9e-05	0.00455	CbGpPWpGaD
Indacaterol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	2.89e-05	0.000756	CcSEcCtD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	2.87e-05	0.00451	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	2.86e-05	0.00449	CbGpPWpGaD
Indacaterol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	2.84e-05	0.00446	CbGpPWpGaD
Indacaterol—Infection—Prednisone—chronic obstructive pulmonary disease	2.84e-05	0.000741	CcSEcCtD
Indacaterol—UGT1A1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	2.82e-05	0.00443	CbGpPWpGaD
Indacaterol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000732	CcSEcCtD
Indacaterol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	2.79e-05	0.000728	CcSEcCtD
Indacaterol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	2.77e-05	0.000725	CcSEcCtD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.7e-05	0.00423	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	2.65e-05	0.00416	CbGpPWpGaD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.65e-05	0.00415	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	2.63e-05	0.00412	CbGpPWpGaD
Indacaterol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.6e-05	0.00068	CcSEcCtD
Indacaterol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.6e-05	0.000679	CcSEcCtD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	2.6e-05	0.00407	CbGpPWpGaD
Indacaterol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	2.58e-05	0.00405	CbGpPWpGaD
Indacaterol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	2.56e-05	0.00067	CcSEcCtD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.52e-05	0.00395	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.51e-05	0.00394	CbGpPWpGaD
Indacaterol—Rash—Prednisolone—chronic obstructive pulmonary disease	2.48e-05	0.000647	CcSEcCtD
Indacaterol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.47e-05	0.000647	CcSEcCtD
Indacaterol—UGT1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.47e-05	0.00388	CbGpPWpGaD
Indacaterol—Headache—Prednisolone—chronic obstructive pulmonary disease	2.46e-05	0.000643	CcSEcCtD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	2.44e-05	0.00383	CbGpPWpGaD
Indacaterol—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	2.44e-05	0.00383	CbGpPWpGaD
Indacaterol—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.33e-05	0.00061	CcSEcCtD
Indacaterol—UGT1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.3e-05	0.00362	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	2.3e-05	0.00361	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	2.27e-05	0.00357	CbGpPWpGaD
Indacaterol—UGT1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.27e-05	0.00357	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	2.22e-05	0.00349	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.18e-05	0.00343	CbGpPWpGaD
Indacaterol—UGT1A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.15e-05	0.00338	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.11e-05	0.00331	CbGpPWpGaD
Indacaterol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.1e-05	0.00055	CcSEcCtD
Indacaterol—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.02e-05	0.000528	CcSEcCtD
Indacaterol—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	2.02e-05	0.00317	CbGpPWpGaD
Indacaterol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.0031	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	1.97e-05	0.00309	CbGpPWpGaD
Indacaterol—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	1.95e-05	0.00306	CbGpPWpGaD
Indacaterol—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.89e-05	0.000493	CcSEcCtD
Indacaterol—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	1.88e-05	0.00295	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	1.87e-05	0.00294	CbGpPWpGaD
Indacaterol—Rash—Prednisone—chronic obstructive pulmonary disease	1.8e-05	0.00047	CcSEcCtD
Indacaterol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.8e-05	0.00047	CcSEcCtD
Indacaterol—Headache—Prednisone—chronic obstructive pulmonary disease	1.79e-05	0.000467	CcSEcCtD
Indacaterol—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	1.77e-05	0.00278	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—APIP—chronic obstructive pulmonary disease	1.76e-05	0.00276	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	1.74e-05	0.00274	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.73e-05	0.00272	CbGpPWpGaD
Indacaterol—Nausea—Prednisone—chronic obstructive pulmonary disease	1.7e-05	0.000443	CcSEcCtD
Indacaterol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.69e-05	0.00266	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	1.66e-05	0.00261	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.6e-05	0.00251	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	1.47e-05	0.00231	CbGpPWpGaD
Indacaterol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.00225	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.43e-05	0.00224	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.42e-05	0.00223	CbGpPWpGaD
Indacaterol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	0.00222	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.39e-05	0.00218	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.3e-05	0.00204	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.27e-05	0.002	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.002	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.25e-05	0.00196	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.21e-05	0.0019	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.19e-05	0.00186	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.16e-05	0.00183	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.00182	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.13e-05	0.00178	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.11e-05	0.00175	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.1e-05	0.00173	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.09e-05	0.00171	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.09e-05	0.0017	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.08e-05	0.00169	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.00169	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	1.07e-05	0.00168	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.05e-05	0.00165	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	1.03e-05	0.00162	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.02e-05	0.0016	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.01e-05	0.00159	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	1.01e-05	0.00159	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.78e-06	0.00154	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.71e-06	0.00152	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.57e-06	0.0015	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.49e-06	0.00149	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.88e-06	0.00139	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	8.75e-06	0.00137	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.69e-06	0.00136	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.59e-06	0.00135	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.5e-06	0.00133	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.49e-06	0.00133	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.4e-06	0.00132	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.38e-06	0.00132	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.31e-06	0.0013	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	8.06e-06	0.00127	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	8.03e-06	0.00126	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	7.5e-06	0.00118	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.09e-06	0.00111	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.99e-06	0.0011	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.89e-06	0.00108	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.74e-06	0.00106	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.51e-06	0.00102	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.51e-06	0.00102	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.42e-06	0.00101	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.37e-06	0.001	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.19e-06	0.000971	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.18e-06	0.000969	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.14e-06	0.000963	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.12e-06	0.00096	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.09e-06	0.000956	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.58e-06	0.000876	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.57e-06	0.000875	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.48e-06	0.000861	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.37e-06	0.000842	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.34e-06	0.000838	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.25e-06	0.000824	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.25e-06	0.000823	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.2e-06	0.000815	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.14e-06	0.000807	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.13e-06	0.000806	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.13e-06	0.000805	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.98e-06	0.000782	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.97e-06	0.00078	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.87e-06	0.000765	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.83e-06	0.000758	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.8e-06	0.000753	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.69e-06	0.000737	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.36e-06	0.000684	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.32e-06	0.000678	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.29e-06	0.000673	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.26e-06	0.000669	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.23e-06	0.000664	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.14e-06	0.00065	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.96e-06	0.000622	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.94e-06	0.000619	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.89e-06	0.00061	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.84e-06	0.000602	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.75e-06	0.000589	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.74e-06	0.000586	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.7e-06	0.000581	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.57e-06	0.00056	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.49e-06	0.000548	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.29e-06	0.000517	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.29e-06	0.000516	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.26e-06	0.000512	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.2e-06	0.000502	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.98e-06	0.000467	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.96e-06	0.000465	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.94e-06	0.000462	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.9e-06	0.000455	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.88e-06	0.000452	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.84e-06	0.000446	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.81e-06	0.00044	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.69e-06	0.000422	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.67e-06	0.00042	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.63e-06	0.000413	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.62e-06	0.000411	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.57e-06	0.000404	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.56e-06	0.000402	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.54e-06	0.000399	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.52e-06	0.000395	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.49e-06	0.00039	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.43e-06	0.000381	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.39e-06	0.000376	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.36e-06	0.00037	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.34e-06	0.000367	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.97e-06	0.000309	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.97e-06	0.000309	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.94e-06	0.000305	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.92e-06	0.000302	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.88e-06	0.000295	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.84e-06	0.000288	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.81e-06	0.000284	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.79e-06	0.000281	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.75e-06	0.000275	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.75e-06	0.000274	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.73e-06	0.000271	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.71e-06	0.000269	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.59e-06	0.00025	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.58e-06	0.000248	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.56e-06	0.000244	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.51e-06	0.000237	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.48e-06	0.000232	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.45e-06	0.000228	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.44e-06	0.000226	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.41e-06	0.000221	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.29e-06	0.000203	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.26e-06	0.000198	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.21e-06	0.00019	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-06	0.000188	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.19e-06	0.000186	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-06	0.000183	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.16e-06	0.000182	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.16e-06	0.000182	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.14e-06	0.000178	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-06	0.000175	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.11e-06	0.000175	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-06	0.000166	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.76e-07	0.000153	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.55e-07	0.00015	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.93e-07	0.00014	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.74e-07	0.000137	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.18e-07	0.000113	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.87e-07	0.000108	CbGpPWpGaD
